SAFETY, EFFICACY AND TOLERABILITY OF ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITORS (ARNI) IN PATIENTS WITH CHRONIC HEART FAILURE. RMSR. 2025;3(1):522-531. Accessed June 3, 2026. https://medicalsciencereview.com/index.php/Journal/article/view/403